The vice president of human resources for biotechnology company BioMarin Pharmaceutical Inc. exercised options for 2,990 shares of common stock under a prearranged trading plan, according to a Securities and Exchange Commission filing Tuesday.
In a Form 4 filed with the SEC, Mark Wood reported he exercised options for the shares Monday for $6.13 to $17.54 apiece, and then sold all of them for $33.79 to $34.11 apiece.
The stock sale was conducted under a prearranged 10b5-1 trading plan which allows a company insider to set up a program in advance for such transactions and proceed with them even if he or she comes into possession of material nonpublic information.
Insiders file Form 4s with the SEC to report transactions in their companies' shares. Open market purchases and sales must be reported within two business days of the transaction.
BioMarin Pharmaceutical is based in Novato, Calif.